Home > Healthcare & Medical Devices > Anatomic Pathology Market

Anatomic Pathology Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI3919

Anatomic Pathology Market Size is expected to gain remarkable momentum between 2022 and 2028, owing to the significant advancement in the fields of biomedicine, genetics, and molecular biology. Likewise, the increasing contribution of pathologists to health through the detection of potential disease development and monitoring of the treatment will also bolster the demand for anatomic diagnosis in the coming years. Anatomic pathology refers to the branch of medicine concerned with the study of the effect of disease and the body organ structure, both microscopically and as a whole. Its primary role is to identify abnormalities that can help diagnose disease and manage the treatment of conditions including autoimmune disorders and kidney diseases.
 

Increasing aging population and the rising prevalence of cancer are among the prominent trends stimulating the overall market expansion through 2028. According to research presented at the annual meeting of the European Society of Medical Oncology, cancer incidence is likely to surge by 21% between 2020-2040. This factor could augment the industry size, given the adoption of anatomic pathology services to help manage various tumor types. Furthermore, the rapid development of pathology labs in developing countries will also generate growth opportunities for the industry during the forecast period.
 

Drug discovery is set to emerge as a key application segment for the market by 2028. This is given the increased need for clinical and anatomic pathology datasets in evaluating the safety, efficacy, and toxicity of drugs during their preclinical stage of development. In light of the COVID-19 pandemic, the U.S. FDA has introduced a special emergency program, known as the Coronavirus Treatment Acceleration Program, to support the trial and testing of new treatments and drugs. These aforesaid factors are anticipated to further propel the requirement of anatomic pathology labs for drug discovery in the coming years.
 

The Middle East and Africa anatomic pathology market is poised to depict a strong growth rate through 2028. The regional growth is driven by the heightened risks of colorectal cancer among the adult population and the growing incidence of kidney disease in countries such as Saudi Arabia and the UAE. In 2021, Saudi Arabia’s National IHR Focal Point reported new cases of Middle East Respiratory Syndrome Coronavirus. This rise of chronic infections will provide a scope for the anatomic pathology business to expand considerably for managed treatment in the region.
 

Key anatomic pathology industry participants include Roche, Danaher, Thermo Fisher Scientific, Sakura Finetek, Quest Diagnostics, NeoGenomics Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies, and Abbott, among others. These firms are implementing strategies like mergers and acquisitions to launch new services and reinforce their presence in the competitive market.
 

For example, in October 2021, Roche inked an agreement with Ibex Medical Analytics, with an aim to help pathologists that use Roche Digital Pathology gain access to Ibex’s tools, including algorithms that examine prostate and breast biopsies. In May 2021, Quest Diagnostics partnered with Paige AI to merge its AI capabilities, as well as digitized pathology slide data, with the scale and pathology expertise of Quest to support the diagnosis of solid tumors.
 

Impact of COVID-19 on Anatomic Pathology Market Trends:

Dramatic reduction in patient referrals for management and investigation of cancer and other diseases has been witnessed in the wake of the deadly coronavirus pandemic. Among the most immediate effects of the outbreak was a slump in the number of specimens being submitted to the pathology labs. These factors have created a hindrance to the global anatomic pathology industry dynamics in recent months. However, the high emphasis on the development of cancer workforces in the field of pathology, due to the substantial delay in diagnosis and increase in backlogs, may help the industry recover in the coming years.
 

The market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

Market, by Product

  • Instruments
  • Consumables

Market, by Application

  • Disease Diagnosis
  • Drug Discovery
  • Others

Market, by End-user

  • Hospitals
  • Diagnostic Centers
  • Research Organizations

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

 

What Information does this report contain?

Historical data coverage: 2017 to 2021; Growth Projections: 2022 to 2028.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Budget constraints? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability